Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds - Business Wire

Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds  Business Wire

Comments

Popular posts from this blog

Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction - Contemporary Obgyn

Sarcoidosis: Causes, Symptoms, Diagnosis & Treatment

BTS Clinical Statement on air travel for passengers with respiratory disease - Thorax (BMJ)